{"version":"1.0","type":"link","title":"CHK1 inhibition by prexasertib sensitizes cisplatin-resistant malignant tumor cells via checkpoint abrogation and STAT1-driven PD-L1 upregulation.","author_name":"Zhang J 외","author_url":"https://prs-insight.online/author/Zhang%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/168294","thumbnail_width":1200,"thumbnail_height":630}